221 related articles for article (PubMed ID: 20832403)
1. A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.
Solbrig MV; Fan Y; Hermanowicz N; Morgese MG; Giuffrida A
Exp Neurol; 2010 Nov; 226(1):231-41. PubMed ID: 20832403
[TBL] [Abstract][Full Text] [Related]
2. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.
Solbrig MV; Hermanowicz N
J Neurovirol; 2008 May; 14(3):252-60. PubMed ID: 18569459
[TBL] [Abstract][Full Text] [Related]
4. Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats.
Bortolato M; Bini V; Frau R; Devoto P; Pardu A; Fan Y; Solbrig MV
Eur Neuropsychopharmacol; 2014 Jun; 24(6):974-85. PubMed ID: 24630433
[TBL] [Abstract][Full Text] [Related]
5. WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination.
Sun J; Fang Y; Chen T; Guo J; Yan J; Song S; Zhang L; Liao H
Brain Res; 2013 Jan; 1491():225-35. PubMed ID: 23148948
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain.
Marchalant Y; Brothers HM; Wenk GL
Mol Psychiatry; 2009 Dec; 14(12):1068-9. PubMed ID: 19920834
[No Abstract] [Full Text] [Related]
9. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis.
Marchalant Y; Brothers HM; Norman GJ; Karelina K; DeVries AC; Wenk GL
Neurobiol Dis; 2009 May; 34(2):300-7. PubMed ID: 19385063
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.
Marchalant Y; Rosi S; Wenk GL
Neuroscience; 2007 Feb; 144(4):1516-22. PubMed ID: 17178196
[TBL] [Abstract][Full Text] [Related]
11. Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.
Enayatfard L; Rostami F; Nasoohi S; Oryan S; Ahmadiani A; Dargahi L
Neuromolecular Med; 2013 Sep; 15(3):523-35. PubMed ID: 23794089
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
[TBL] [Abstract][Full Text] [Related]
13. The Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling.
Du JJ; Liu ZQ; Yan Y; Xiong J; Jia XT; Di ZL; Ren JJ
J Mol Neurosci; 2020 Mar; 70(3):422-432. PubMed ID: 31732924
[TBL] [Abstract][Full Text] [Related]
14. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A
Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.
Xu C; Hermes DJ; Mackie K; Lichtman AH; Ignatowska-Jankowska BM; Fitting S
J Neuroimmune Pharmacol; 2016 Jun; 11(2):316-31. PubMed ID: 26993829
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
Ganon-Elazar E; Akirav I
Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
[TBL] [Abstract][Full Text] [Related]
19. The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.
Hao MX; Jiang LS; Fang NY; Pu J; Hu LH; Shen LH; Song W; He B
J Lipid Res; 2010 Aug; 51(8):2181-90. PubMed ID: 20305287
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia.
Fernández-López D; Pradillo JM; García-Yébenes I; Martínez-Orgado JA; Moro MA; Lizasoain I
Stroke; 2010 Dec; 41(12):2956-64. PubMed ID: 21115947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
